Gamma-aminobutyric acid: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 132: Line 132:
{{LabelImage
{{LabelImage
|fileName=DailyMed - GABA PHENOLIC - .gamma.-aminobutyric acid liquid .png
|fileName=DailyMed - GABA PHENOLIC - .gamma.-aminobutyric acid liquid .png
}}
}}
}}
<!--Pill Image-->
<!--Pill Image-->

Revision as of 20:23, 3 April 2015

Gamma-aminobutyric acid
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Gamma-aminobutyric acid is a anxiolytic that is FDA approved for the treatment of epilepsy. Common adverse reactions include hypersensitivity.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. If symptoms persist, consult your health care professional. Consult a physician for use in children under 12 years of age.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Gamma-aminobutyric acid in adult patients.

Non–Guideline-Supported Use

epilepsy, tardive dyskinesia, spasicity

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Gamma-aminobutyric acid in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Gamma-aminobutyric acid in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Gamma-aminobutyric acid in pediatric patients.

Contraindications

  • Hypersensitivity to GABA

Warnings

  • WARNINGS: If pregnant or breast-feeding, ask a health professional before use.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Gamma-aminobutyric acid in the drug label.

Postmarketing Experience

Visual defects with vigabatrin administration flushing, euphoria, anxiety increased blood pressure and heart rate

Drug Interactions

  • Drug
  • Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Pregnancy Category


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Gamma-aminobutyric acid in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Gamma-aminobutyric acid during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Gamma-aminobutyric acid with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Gamma-aminobutyric acid with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Gamma-aminobutyric acid with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Gamma-aminobutyric acid with respect to specific gender populations.

Race

There is no FDA guidance on the use of Gamma-aminobutyric acid with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Gamma-aminobutyric acid in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Gamma-aminobutyric acid in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Gamma-aminobutyric acid in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Gamma-aminobutyric acid in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Oral

Monitoring

There is limited information regarding Monitoring of Gamma-aminobutyric acid in the drug label.

  • Description

IV Compatibility

There is limited information regarding IV Compatibility of Gamma-aminobutyric acid in the drug label.

Overdosage

Acute Overdose

Signs and Symptoms

  • Description

Management

  • Description

Chronic Overdose

There is limited information regarding Chronic Overdose of Gamma-aminobutyric acid in the drug label.

Pharmacology

There is limited information regarding Gamma-aminobutyric acid Pharmacology in the drug label.

Mechanism of Action

Structure

File:Gamma-aminobutyric acid01.png
This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Gamma-aminobutyric acid in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Gamma-aminobutyric acid in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Gamma-aminobutyric acid in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Gamma-aminobutyric acid in the drug label.

How Supplied

Storage

There is limited information regarding Gamma-aminobutyric acid Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Gamma-aminobutyric acid |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Gamma-aminobutyric acid |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Gamma-aminobutyric acid in the drug label.

Precautions with Alcohol

  • Alcohol-Gamma-aminobutyric acid interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

  • GABA PHENOLIC ®[1]

Look-Alike Drug Names

There is limited information regarding Gamma-aminobutyric acid Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. "GABA PHENOLIC - .gamma.-aminobutyric acid liquid".

{{#subobject:

 |Label Page=Gamma-aminobutyric acid
 |Label Name=GABA 01.jpg

}}

{{#subobject:

 |Label Page=Gamma-aminobutyric acid
 |Label Name=DailyMed - GABA PHENOLIC - .gamma.-aminobutyric acid liquid .png

}}

}}